Phenotypic and Genomic Comparison of <i>staphylococcus Aureus</i> Highlights Virulence and Host Adaptation Favoring the Success of Epidemic Clones

Fengning Chen,Yuyao Yin,Hongbin Chen,Longyang Jin,Shuguang Li,Ruobing Wang,Shuyi Wang,Qi Wang,Shijun Sun,Hui Wang

DOI: https://doi.org/10.2139/ssrn.4117380

2022-01-01

SSRN Electronic Journal

Abstract:Background: Staphylococcus aureus has great population diversity, but relative few clones dominate in specific regions. A dramatic decrease in S. aureus ST239 and the emergence of ST59 in hospitals has been observed in recent years.Methods: A total of 142 S. aureus strains were selected from our seven-year national surveillance of S. aureus bloodstream infections (n=983). A combination of phenotypic and genomic analyse was applied to identify factors that contribute to the success of the epidemic clones, ST59 and ST398.Findings: Specific genetic traits such as the protease-associated genes hysAVSaβ, paiB, and cfim had a higher prevalence in ST59 and ST398, and we demonstrated that ST59 and ST398 had enhanced proteolysis capacities. The cytolytic abilities of ST59, ST398, and ST5-MSSA were enhanced with higher expression of psmα and RNAIII. Notably, the sphingomyelinase gene hlb remained intact in ST59 and was highly expressed compared with the other clones. While interacting with neutrophils, ST59 induced more neutrophil extracellular trap (NETs) formation and degradation. Besides differences in virulence, it is worth noting that ST398 displayed higher adaptability to human keratinocytes and a unique genetic arrangement inside the oligopeptide ABC transport system, indicating functional variations.Interpretation: Overall, our comparative study demonstrated that virulence and fitness contributed to the epidemic success of ST59 and ST398, and we revealed some potential genomic traits associated with virulence and fitness that might account for the success of epidemic clones.Funding Information: This work was supported by the National Natural Science Foundation of China (NSFC) grant (81991533).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: Bacterial strains were collected in routine clinical diagnostics, and ethical approval and consent to participate from patients were not required. The analysis of de-identified patient demographic data was approved by the Peking University People’s Hospital Institutional Review Board (no. 2020PHB193-01). The study conformed to the principles of the Declaration of Helsinki and its later amendments.